|
1
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hoang MT and Eichenfield LF: The rising
incidence of melanoma in children and adolescents. Dermatol Nurs.
12:188–189. 2000.PubMed/NCBI
|
|
3
|
Dudek-Peric AM, Ferreira GB, Muchowicz A,
Wouters J, Prada N, Martin S, Kiviluoto S, Winiarska M, Boon L,
Mathieu C, et al: Antitumor immunity triggered by melphalan is
potentiated by melanoma cell surface-associated calreticulin.
Cancer Res. 75:1603–1614. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ribas A, Hamid O, Daud A, Hodi FS, Wolchok
JD, Kefford R, Joshua AM, Patnaik A, Hwu WJ, Weber JS, et al:
ssociation of pembrolizumab with tumor response and survival among
patients with advanced melanoma. JAMA. 315:1600–1609. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bandarchi B, Jabbari CA, Vedadi A and
Navab R: Molecular biology of normal melanocytes and melanoma
cells. J Clin Pathol. 66:644–648. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Croce CM: Oncogenes and cancer. N Engl J
Med. 358:502–511. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao H, Tang W, Chen X, Wang S, Wang X, Xu
H and Li L: The NAMPT/E2F2/SIRT1 axis promotes proliferation and
inhibits p53-dependent apoptosis in human melanoma cells. Biochem
Biophys Res Commun. 493:77–84. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Levings PP, McGarry SV, Currie TP,
Nickerson DM, McClellan S, Ghivizzani SC, Steindler DA and Gibbs
CP: Expression of an exogenous human Oct-4 promoter identifies
tumor-initiating cells in osteosarcoma. Cancer Res. 69:5648–5655.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Beltran AS, Rivenbark AG, Richardson BT,
Yuan X, Quian H, Hunt JP, Zimmerman E, Graves LM and Blancafort P:
Generation of tumor-initiating cells by exogenous delivery of OCT4
transcription factor. Breast Cancer Res. 13:942011. View Article : Google Scholar
|
|
11
|
Corominas-Faja B, Cufi S,
Oliveras-Ferraros C, Cuyàs E, López-Bonet E, Lupu R, Alarcón T,
Vellon L, Iglesias JM, Leis O, et al: Nuclear reprogramming of
luminal-like breast cancer cells generates Sox2-overexpressing
cancer stem-like cellular states harboring transcriptional
activation of the mTOR pathway. Cell cycle. 12:3109–31024. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Mou Y, Zhang H, Wang X, Li R,
Cheng Z and Liu X: Reprogramming factors remodel melanoma cell
phenotype by changing Stat3 expression. Int J Med Sci.
14:1402–1409. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Wei Y, Zhang H, Shi Y, Li Y and Li
R: Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63
cells through the inhibition of catalase. Med Oncol. 29:1328–1334.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sherr CJ: Principles of tumor suppression.
Cell. 116:235–246. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pan XW, Chen L, Hong Y, Xu DF, Liu X, Li
L, Huang Y, Cui LM, Gan SS, Yang QW, et al: EIF3D silencing
suppresses renal cell carcinoma tumorigenesis via inducing G2/M
arrest through downregulation of Cyclin B1/CDK1 signaling. Int J
Oncol. 48:2580–2590. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kralovics R, Passamonti F, Buser AS, Teo
SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M and Skoda RC: A
gain-of-function mutation of JAK2 in myeloproliferative disorders.
N Engl J Med. 352:1779–1790. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu J, Zhou W, Yang F, Chen G, Li H, Zhao
Y, Liu P, Li H, Tan M, Xiong X and Sun Y: The beta-TrCP-FBXW2-SKP2
axis regulates lung cancer cell growth with FBXW2 acting as a
tumour suppressor. Nat commun. 8:140022017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ashkenazi A, Fairbrother WJ, Leverson JD
and Souers AJ: From basic apoptosis discoveries to advanced
selective BCL-2 family inhibitors. Nat Rev Drug Discov. 16:273–284.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carrington EM, Tarlinton DM, Gray DH,
Huntington ND, Zhan Y and Lew AM: The life and death of immune cell
types: The role of BCL-2 anti-apoptotic molecules. Immunol Cell
Biol. 95:870–877. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Herr I and Debatin KM: Cellular stress
response and apoptosis in cancer therapy. Blood. 98:2603–2614.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ferraz da Costa DC, Fialho E and Silva JL:
Cancer chemoprevention by resveratrol: The p53 tumor suppressor
protein as a promising molecular target. Molecules. 22:2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hainaut P and Plymoth A: Targeting the
hallmarks of cancer: Towards a rational approach to next-generation
cancer therapy. Curr Opin Oncol. 25:50–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hockemeyer D, Soldner F, Cook EG, Gao Q,
Mitalipova M and Jaenisch R: A drug-inducible system for direct
reprogramming of human somatic cells to pluripotency. Cell Stem
Cell. 3:346–353. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carey BW, Markoulaki S, Hanna J, Saha K,
Gao Q, Mitalipova M and Jaenisch R: Reprogramming of murine and
human somatic cells using a single polycistronic vector. Proc Nati
Acad Sci USA. 106:157–162. 2009. View Article : Google Scholar
|
|
25
|
Imran A, Qamar HY, Ali Q, Naeem H, Riaz M,
Amin S, Kanwal N, Ali F, Sabar MF and Nasir IA: Role of molecular
biology in cancer treatment: A review article. Iran J Public
Health. 46:1475–1485. 2017.PubMed/NCBI
|
|
26
|
Celia-Terrassa T and Kang Y: Distinctive
properties of metastasis-initiating cells. Genes Dev. 30:892–908.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo L, Karoubi G, Duchesneau P, Shutova
MV, Sung HK, Tonge P, Bear C, Rogers I, Nagy A and Waddell TK:
Generation of induced progenitor-like cells from mature epithelial
cells using interrupted reprogramming. Stem Cell Reports.
9:1780–1795. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gramolelli S and Ojala PM: Kaposi's
sarcoma herpesvirus-induced endothelial cell reprogramming supports
viral persistence and contributes to Kaposi's sarcoma
tumorigenesis. Curr Opin Virol. 26:156–162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qian X, Tan C, Yang B, Wang F, Ge Y, Guan
Z and Cai J: Astaxanthin increases radiosensitivity in esophageal
squamous cell carcinoma through inducing apoptosis and G2/M arrest.
Dis Esophagus. 30:1–7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Toyoshima-Morimoto F, Taniguchi E, Shinya
N, Iwamatsu A and Nishida E: Polo-like kinase 1 phosphorylates
cyclin B1 and targets it to the nucleus during prophase. Nature.
410:215–220. 2001. View
Article : Google Scholar : PubMed/NCBI
|
